Items where Author is "Rothery, Claire"

[Atom feed] Atom [RSS2 feed] RSS
Group by: Item Type | Full Text | No Grouping
Jump to: Restricted | Public
Number of items: 3.

Restricted

file
WOODS, Beth, KEARNS, Ben, SCHMITT, Laetitia, JANKOVIC, Dina, ROTHERY, Claire, HARNAN, Sue, HAMILTON, Jean, SCOPE, Alison, REN, Shijie, BOJKE, Laura, WILCOX, Mark, HOPE, William, LEONARD, Colm, HOWARD, Philip, JENKINS, David, ASHWORTH, Alan, BENTLEY, Andrew and SCULPHER, Mark (2025). Assessing the Value of New Antimicrobials: Evaluations of Cefiderocol and Ceftazidime-Avibactam to Inform Delinked Payments by the NHS in England. Applied Health Economics and Health Policy, 23 (1), 5-17. [Article]

Public

file
HARNAN, Sue, KEARNS, Ben, SCOPE, Alison, SCHMITT, Laetitia, JANKOVIC, Dina, HAMILTON, Jean, SRIVASTAVA, Tushar, HILL, Harry, KU, Chu Chang, REN, Shijie, ROTHERY, Claire, BOJKE, Laura, SCULPHER, Mark and WOODS, Beth (2024). Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model. Health technology assessment (Winchester, England), 28 (73), 1-230. [Article]

file
WOODS, Beth, SCHMITT, Laetitia, JANKOVIC, Dina, KEARNS, Benjamin, SCOPE, Alison, REN, Shijie, SRIVASTAVA, Tushar, KU, Chu Chang, HAMILTON, Jean, ROTHERY, Claire, BOJKE, Laura, SCULPHER, Mark and HARNAN, Sue (2024). Cefiderocol for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model. Health technology assessment (Winchester, England), 28 (28), 1-238. [Article]

This list was generated on Sat Feb 8 06:46:37 2025 UTC.